Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer; Melanie E. Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B. Ottevanger; Jonathan A. Ledermann; Pearly Khaw; Romerai D'Amico; Anthony Fyles; Marie-Helene Baron; Ina M. Jurgenliemk-Schulz; Henry C. Kitchener; Hans W. Nijman; Godfrey Wilson; Susan Brooks; Sergio Gribaudo; Diane Provencher; Chantal Hanzen; Roy F. Kruitwagen; Vincent T. H. B. M. Smit; Naveena Singh; Viet Do; Andrea Lissoni; Remi A. Nout; Amanda Feeney; Karen W. Verhoeven-Adema; Hein Putter; Carien L. Creutzberg; PORTEC Study Grp

doi:10.1016/S1470-2045(19)30395-X

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer^*, Melanie E. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B. Ottevanger, Jonathan A. Ledermann, Pearly Khaw, Romerai D'Amico, Anthony Fyles, Marie-Helene Baron, Ina M. Jurgenliemk-Schulz, Henry C. Kitchener, Hans W. Nijman, Godfrey Wilson, Susan Brooks, Sergio Gribaudo, Diane Provencher, Chantal HanzenRoy F. Kruitwagen, Vincent T. H. B. M. Smit, Naveena Singh, Viet Do, Andrea Lissoni, Remi A. Nout, Amanda Feeney, Karen W. Verhoeven-Adema, Hein Putter, Carien L. Creutzberg, PORTEC Study Grp

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

119 Citations (Web of Science)

Original language	English
Pages (from-to)	1273-1285
Number of pages	13
Journal	Lancet oncology
Volume	20
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(19)30395-X
Publication status	Published - Sep 2019

Keywords

CARCINOMA PATIENTS
OPEN-LABEL
III TRIAL
CHEMOTHERAPY
RADIATION
MULTICENTER
IRRADIATION
THERAPY

Access to Document

10.1016/S1470-2045(19)30395-XLicence: CC BY

Cite this

de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M-H., Jurgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Gribaudo, S., Provencher, D., ... PORTEC Study Grp (2019). Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Lancet oncology, 20(9), 1273-1285. https://doi.org/10.1016/S1470-2045(19)30395-X

de Boer, Stephanie M. ; Powell, Melanie E. ; Mileshkin, Linda ; Katsaros, Dionyssios ; Bessette, Paul ; Haie-Meder, Christine ; Ottevanger, Petronella B. ; Ledermann, Jonathan A. ; Khaw, Pearly ; D'Amico, Romerai ; Fyles, Anthony ; Baron, Marie-Helene ; Jurgenliemk-Schulz, Ina M. ; Kitchener, Henry C. ; Nijman, Hans W. ; Wilson, Godfrey ; Brooks, Susan ; Gribaudo, Sergio ; Provencher, Diane ; Hanzen, Chantal ; Kruitwagen, Roy F. ; Smit, Vincent T. H. B. M. ; Singh, Naveena ; Do, Viet ; Lissoni, Andrea ; Nout, Remi A. ; Feeney, Amanda ; Verhoeven-Adema, Karen W. ; Putter, Hein ; Creutzberg, Carien L. ; PORTEC Study Grp. / Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. In: Lancet oncology. 2019 ; Vol. 20, No. 9. pp. 1273-1285.

@article{7e186df2936a4c0a871cc3c40735eb28,

title = "Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial",

keywords = "CARCINOMA PATIENTS, OPEN-LABEL, III TRIAL, CHEMOTHERAPY, RADIATION, MULTICENTER, IRRADIATION, THERAPY",

author = "{de Boer}, {Stephanie M.} and Powell, {Melanie E.} and Linda Mileshkin and Dionyssios Katsaros and Paul Bessette and Christine Haie-Meder and Ottevanger, {Petronella B.} and Ledermann, {Jonathan A.} and Pearly Khaw and Romerai D'Amico and Anthony Fyles and Marie-Helene Baron and Jurgenliemk-Schulz, {Ina M.} and Kitchener, {Henry C.} and Nijman, {Hans W.} and Godfrey Wilson and Susan Brooks and Sergio Gribaudo and Diane Provencher and Chantal Hanzen and Kruitwagen, {Roy F.} and Smit, {Vincent T. H. B. M.} and Naveena Singh and Viet Do and Andrea Lissoni and Nout, {Remi A.} and Amanda Feeney and Verhoeven-Adema, {Karen W.} and Hein Putter and Creutzberg, {Carien L.} and {PORTEC Study Grp}",

year = "2019",

month = sep,

doi = "10.1016/S1470-2045(19)30395-X",

language = "English",

volume = "20",

pages = "1273--1285",

journal = "Lancet oncology",

issn = "1470-2045",

publisher = "Elsevier Science",

number = "9",

}

de Boer, SM, Powell, ME, Mileshkin, L, Katsaros, D, Bessette, P, Haie-Meder, C, Ottevanger, PB, Ledermann, JA, Khaw, P, D'Amico, R, Fyles, A, Baron, M-H, Jurgenliemk-Schulz, IM, Kitchener, HC, Nijman, HW, Wilson, G, Brooks, S, Gribaudo, S, Provencher, D, Hanzen, C, Kruitwagen, RF, Smit, VTHBM, Singh, N, Do, V, Lissoni, A, Nout, RA, Feeney, A, Verhoeven-Adema, KW, Putter, H, Creutzberg, CL & PORTEC Study Grp 2019, 'Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial', Lancet oncology, vol. 20, no. 9, pp. 1273-1285. https://doi.org/10.1016/S1470-2045(19)30395-X

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. / de Boer, Stephanie M.; Powell, Melanie E.; Mileshkin, Linda; Katsaros, Dionyssios; Bessette, Paul; Haie-Meder, Christine; Ottevanger, Petronella B.; Ledermann, Jonathan A.; Khaw, Pearly; D'Amico, Romerai; Fyles, Anthony; Baron, Marie-Helene; Jurgenliemk-Schulz, Ina M.; Kitchener, Henry C.; Nijman, Hans W.; Wilson, Godfrey; Brooks, Susan; Gribaudo, Sergio; Provencher, Diane; Hanzen, Chantal; Kruitwagen, Roy F.; Smit, Vincent T. H. B. M.; Singh, Naveena; Do, Viet; Lissoni, Andrea; Nout, Remi A.; Feeney, Amanda; Verhoeven-Adema, Karen W.; Putter, Hein; Creutzberg, Carien L.; PORTEC Study Grp.

In: Lancet oncology, Vol. 20, No. 9, 09.2019, p. 1273-1285.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3)

T2 - patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

AU - de Boer, Stephanie M.

AU - Powell, Melanie E.

AU - Mileshkin, Linda

AU - Katsaros, Dionyssios

AU - Bessette, Paul

AU - Haie-Meder, Christine

AU - Ottevanger, Petronella B.

AU - Ledermann, Jonathan A.

AU - Khaw, Pearly

AU - D'Amico, Romerai

AU - Fyles, Anthony

AU - Baron, Marie-Helene

AU - Jurgenliemk-Schulz, Ina M.

AU - Kitchener, Henry C.

AU - Nijman, Hans W.

AU - Wilson, Godfrey

AU - Brooks, Susan

AU - Gribaudo, Sergio

AU - Provencher, Diane

AU - Hanzen, Chantal

AU - Kruitwagen, Roy F.

AU - Smit, Vincent T. H. B. M.

AU - Singh, Naveena

AU - Do, Viet

AU - Lissoni, Andrea

AU - Nout, Remi A.

AU - Feeney, Amanda

AU - Verhoeven-Adema, Karen W.

AU - Putter, Hein

AU - Creutzberg, Carien L.

AU - PORTEC Study Grp

PY - 2019/9

Y1 - 2019/9

KW - CARCINOMA PATIENTS

KW - OPEN-LABEL

KW - III TRIAL

KW - CHEMOTHERAPY

KW - RADIATION

KW - MULTICENTER

KW - IRRADIATION

KW - THERAPY

U2 - 10.1016/S1470-2045(19)30395-X

DO - 10.1016/S1470-2045(19)30395-X

M3 - Article

VL - 20

SP - 1273

EP - 1285

JO - Lancet oncology

JF - Lancet oncology

SN - 1470-2045

IS - 9

ER -